Data Characteristics in this Category
Pharmacovigilance data in metabolism and endocrinology primarily comes from clinical trial reports, real-world evidence (RWE), post-market surveillance, and spontaneous patient reports. The update frequency is relatively high, especially during the initial launch of new drugs, where data volume grows rapidly before stabilizing with continuous minor updates. Document structures are diverse, including structured Case Report Forms (CRFs), unstructured medical texts (e.g., handwritten doctor's notes, patient feedback), and semi-structured Electronic Health Record (EHR) snippets. Data fields include basic patient information, medication history, comorbidities, adverse event (AE) descriptions, severity, outcomes, and causality assessments. A common challenge involves unit conversion and range standardization for physiological indicators like blood glucose, blood pressure, and blood lipids; for example, blood glucose values might be recorded in mmol/L or mg/dL.
Constraints Imposed by These Characteristics on Deployment and Upgrade
The heterogeneous nature of metabolism and endocrinology pharmacovigilance data requires deployment solutions with robust data integration and preprocessing capabilities. Frequent data updates, particularly from post-market surveillance data streams, demand high requirements for real-time synchronization and incremental update mechanisms in the knowledge base to prevent outdated information from affecting decisions. Unstructured text content, such as free-text descriptions of adverse events, necessitates high-performance text segmentation and entity extraction capabilities to accurately identify drugs, symptoms, and associations. Inconsistent physiological indicator units require standardization during data ingestion to ensure accuracy in subsequent retrieval and analysis. Therefore, deployment must focus on data cleaning, knowledge graph construction, and model iteration efficiency. The upgrade process must smoothly handle large-scale data migration and model parameter adjustments while ensuring service continuity.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Accommodates importing single clinical trial reports or large EHRs |
Chunk size (Segment Length) | 800–1200 characters (characters) | Balances semantic integrity with recall precision for free-text length |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Provides sufficient time for OCR and parsing of complex PDFs or scanned documents |
Similarity threshold (Similarity Threshold) | 0.75 | Ensures high relevance of recall results to query intent, reducing false positives |
Rerank result count (Reranked Results Count) | 10 entries (items) | Provides enough information for manual review while maintaining accuracy |
maxContext | 32000 token | Supports contextual understanding of lengthy adverse event reports |
Three Common Pitfalls
- After a knowledge base update, some old drug adverse reaction associations are not covered by new data, leading to outdated information in search results. This occurs when incremental update strategies incorrectly handle data conflicts or have incomplete merging logic.
- When users query for specific drug side effects, the results contain many irrelevant physiological indicator changes. This happens when the text segmentation strategy does not adequately consider the multi-indicator coexistence unique to metabolism and endocrinology, leading to inaccurate context partitioning.
- After a new version deployment, the system's accuracy in identifying certain specific dosages or administration routes significantly decreases, or even throws a
ValueError: invalid literal for int() with base 10error. This occurs when the new model version has insufficient representation of such entities in its training data, or if unit conversion rules in the data preprocessing pipeline changed without synchronization.
How to Verify Configuration
- Select typical new drug adverse reaction reports and perform knowledge base question-answering tests to verify whether key entities like drugs, adverse events, and dosages are accurately identified and associated.
- Simulate data import from different sources (e.g., CRFs, EHR snippets) in batches. Check if data cleaning, unit standardization, and segmentation results meet expectations, especially for handling blood glucose
mg/dLconversion tommol/L. - After an upgrade, for queries of varying complexity, compare the number of recalled items and accuracy of critical information (e.g., drug interactions, contraindications for specific populations) between old and new model versions. This helps determine a reasonable range for the number of recalled items and the similarity threshold.
- Monitor logs for common deployment errors such as
FileNotFoundErrororConnectionRefusedError. Ensure file parsing tasks complete withinPARSE_FILE_TIMEOUT_SECONDS.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.